Cash flow H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 20/05/2026 pm IST			5-day change	1st Jan Change
41.40 ^DKK	+3.09%		+0.05%	-4.08%

18/05	Lundbeck's Asedebart Secures Orphan Drug Designation in Japan	MT
18/05	Lundbeck granted Orphan Drug Designation in Japan for asedebart	FW

f0.QUvzj6amWLBxwblxFXAEq1_7sZmzNI7XcsTZNAyfNio.dgiju8XKL9489Yo1eRxT3Wy38sHRXtTiKvyqRznlQhw5DrLZ954TwR-T8A

Published financial data: H. LUNDBECK A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.63TCr	1.82TCr	1.99TCr	2.2TCr	2.46TCr
Total Revenues	1.63TCr	1.82TCr	1.99TCr	2.2TCr	2.46TCr
Cost of Goods Sold, Total	361.1Cr	395.1Cr	448.5Cr	423Cr	426.5Cr
Gross Profit	1.27TCr	1.43TCr	1.54TCr	1.78TCr	2.04TCr
Selling General & Admin Expenses, Total	662.5Cr	782.2Cr	870.6Cr	943.3Cr	922.6Cr
R&D Expenses	382Cr	375.9Cr	345.7Cr	395.4Cr	426Cr
Other Operating Expenses	-	-	-	-	100Cr
Other Operating Expenses, Total	1.04TCr	1.16TCr	1.22TCr	1.34TCr	1.45TCr
Operating Income	224.3Cr	271.4Cr	326.4Cr	438.7Cr	588.2Cr
Interest Expense, Total	-15Cr	-10Cr	-5.4Cr	-11Cr	-51Cr
Interest And Investment Income	70L	2.2Cr	8.6Cr	22Cr	20Cr
Net Interest Expenses	-15Cr	-8.1Cr	3.2Cr	10Cr	-32Cr
Currency Exchange Gains (Loss)	-3.1Cr	-3Cr	-16Cr	-1.4Cr	-35Cr
Other Non Operating Income (Expenses)	-6.1Cr	-6.2Cr	-4.3Cr	-4.1Cr	-3.2Cr
EBT, Excl. Unusual Items	200.5Cr	254.1Cr	308.9Cr	443.7Cr	518.6Cr
Restructuring Charges	-23Cr	14Cr	-	-	-
Merger & Related Restructuring Charges	-	-	-	-42Cr	2.8Cr
Gain (Loss) On Sale Of Investments	-5.8Cr	2.4Cr	-2.1Cr	38Cr	-30L
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-55Cr	-64Cr
Legal Settlements	-	-	-6.9Cr	-15Cr	-
Other Unusual Items	-13Cr	-23Cr	-60L	2.1Cr	-8.9Cr
EBT, Incl. Unusual Items	158.1Cr	247.4Cr	299.3Cr	371.9Cr	448.7Cr
Income Tax Expense	26Cr	56Cr	70Cr	58Cr	129.5Cr
Earnings From Continuing Operations	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Net Income to Company	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Net Income - (IS)	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Net Income to Common Incl Extra Items	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Net Income to Common Excl. Extra Items	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Per Share Items
Net EPS - Basic	1.33	1.93	2.31	3.17	3.22
Basic EPS - Continuing Operations	1.33	1.93	2.31	3.17	3.22
Basic Weighted Average Shares Outstanding	99Cr	99Cr	99Cr	99Cr	99Cr
Net EPS - Diluted	1.33	1.93	2.31	3.17	3.22
Diluted EPS - Continuing Operations	1.33	1.93	2.31	3.17	3.22
Diluted Weighted Average Shares Outstanding	99Cr	99Cr	99Cr	99Cr	99Cr
Normalized Basic EPS	1.26	1.6	1.95	2.8	3.27
Normalized Diluted EPS	1.26	1.6	1.95	2.8	3.27
Dividend Per Share	0.4	0.58	0.7	0.95	1.15
Payout Ratio	37.71	20.72	25.15	22.08	29.54
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	386.7Cr	443.2Cr	518.6Cr	617.4Cr	765.5Cr
EBITA	358.5Cr	414.8Cr	488.3Cr	587.2Cr	736.5Cr
EBIT	224.3Cr	271.4Cr	326.4Cr	438.7Cr	588.2Cr
EBITDAR	386.9Cr	443.4Cr	518.7Cr	617.7Cr	765.7Cr
Effective Tax Rate - (Ratio)	16.64	22.55	23.49	15.49	28.86
Normalized Net Income	125.31Cr	158.81Cr	193.06Cr	277.31Cr	324.12Cr
Interest on Long-Term Debt	70L	70L	1.1Cr	1.3Cr	1.7Cr
Non-Cash Pension Expense	30L	40L	40L	50L	4.9Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	572.3Cr	673.6Cr	748.2Cr	814.6Cr	774.3Cr
General and Administrative Expenses	90Cr	108.6Cr	122.4Cr	128.7Cr	148.3Cr
Research And Development Expense From Footnotes	382.3Cr	375.4Cr	345.7Cr	450.1Cr	489.5Cr
Net Rental Expense, Total	20L	20L	10L	30L	20L
Imputed Operating Lease Interest Expense	4L	3L	88.79T	3L	6L
Imputed Operating Lease Depreciation	16.29L	16.98L	9L	27.4L	14.2L
Stock-Based Comp., Other (Total)	4.1Cr	3.4Cr	4.1Cr	4.7Cr	6Cr
Total Stock-Based Compensation	4.1Cr	3.4Cr	4.1Cr	4.7Cr	6Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	227.9Cr	354.8Cr	501Cr	466.4Cr	343.3Cr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	227.9Cr	354.8Cr	501Cr	466.4Cr	343.3Cr
Accounts Receivable, Total	245.9Cr	270.9Cr	296.5Cr	343.2Cr	360.5Cr
Other Receivables	47Cr	85Cr	66Cr	59Cr	94Cr
Total Receivables	293.1Cr	356.3Cr	362.6Cr	402.3Cr	455Cr
Inventory	277.5Cr	404.6Cr	442.7Cr	398.3Cr	447.3Cr
Prepaid Expenses	63Cr	26Cr	23Cr	34Cr	33Cr
Total Current Assets	861.2Cr	1.14TCr	1.33TCr	1.3TCr	1.28TCr
Gross Property Plant And Equipment	713.6Cr	731.4Cr	763.2Cr	807.2Cr	816.7Cr
Accumulated Depreciation	-484.1Cr	-507.8Cr	-538.6Cr	-570.6Cr	-633.4Cr
Net Property Plant And Equipment	229.5Cr	223.6Cr	224.6Cr	236.6Cr	183.3Cr
Long-term Investments	5.7Cr	17Cr	9.9Cr	6.7Cr	3.2Cr
Goodwill	537.7Cr	566.7Cr	550.7Cr	983.2Cr	700.8Cr
Other Intangibles, Total	1.74TCr	1.68TCr	1.52TCr	3.03TCr	2.88TCr
Deferred Tax Assets Long-Term	19Cr	23Cr	24Cr	27Cr	24Cr
Other Long-Term Assets, Total	75Cr	90Cr	84Cr	110Cr	139Cr
Total Assets	3.47TCr	3.75TCr	3.74TCr	5.7TCr	5.21TCr
Liabilities
Accounts Payable, Total	391.4Cr	425.1Cr	441Cr	437Cr	466.3Cr
Accrued Expenses, Total	92Cr	179.2Cr	184Cr	216.3Cr	199.7Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	8.6Cr	8.8Cr	8.6Cr	8.2Cr	7.4Cr
Current Income Taxes Payable	52Cr	54Cr	57Cr	32Cr	69Cr
Other Current Liabilities	337.5Cr	153.3Cr	108.3Cr	164.9Cr	142.6Cr
Total Current Liabilities	881.8Cr	819.9Cr	799Cr	858Cr	885.3Cr
Long-Term Debt	478.3Cr	509.6Cr	371.4Cr	1.62TCr	1.12TCr
Long-Term Leases	45Cr	40Cr	35Cr	44Cr	40Cr
Pension & Other Post Retirement Benefits	29Cr	21Cr	22Cr	22Cr	19Cr
Deferred Tax Liability Non Current	144.8Cr	215.2Cr	228.3Cr	553Cr	533.6Cr
Other Non Current Liabilities	58Cr	62Cr	81Cr	102.2Cr	119.4Cr
Total Liabilities	1.64TCr	1.67TCr	1.54TCr	3.2TCr	2.72TCr
Common Stock, Total	100Cr	100Cr	100Cr	100Cr	100Cr
Retained Earnings	1.66TCr	1.82TCr	1.99TCr	2.23TCr	2.46TCr
Comprehensive Income and Other	71Cr	159.4Cr	117.2Cr	168Cr	-71Cr
Total Common Equity	1.83TCr	2.08TCr	2.2TCr	2.5TCr	2.49TCr
Total Equity	1.83TCr	2.08TCr	2.2TCr	2.5TCr	2.49TCr
Total Liabilities And Equity	3.47TCr	3.75TCr	3.74TCr	5.7TCr	5.21TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	99Cr	99Cr	99Cr	99Cr	99Cr
ECS Total Common Shares Outstanding	99Cr	99Cr	99Cr	99Cr	99Cr
Book Value / Share	18.4	20.93	22.22	25.23	25.12
Tangible Book Value	-447.1Cr	-172.1Cr	135.3Cr	-1.52TCr	-1.09TCr
Tangible Book Value Per Share	-4.5	-1.73	1.36	-15.29	-10.97
Total Debt	532.2Cr	557.9Cr	415.1Cr	1.67TCr	1.17TCr
Net Debt	304.3Cr	203.1Cr	-86Cr	1.2TCr	822.1Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	25Cr	12Cr	13Cr	12Cr	11Cr
Debt Equivalent Oper. Leases	1.6Cr	1.6Cr	80L	2.4Cr	1.6Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	21Cr	21Cr	21Cr	20Cr	14Cr
Inventories - Work In Process, Total	153.4Cr	220.7Cr	258Cr	233.5Cr	237.4Cr
Inventories - Finished Goods, Total	103.4Cr	155.7Cr	163.3Cr	145.1Cr	196.4Cr
Inventories - Others	-	7.3Cr	-	-	-
Land - (BS)	353.7Cr	368.5Cr	382.9Cr	398.4Cr	405.5Cr
Machinery, Total	289.4Cr	289.8Cr	304.7Cr	317.6Cr	319.3Cr
Full Time Employees	5.35T	5.45T	5.68T	5.44T	5.04T
Accumulated Allowance for Doubtful Accounts (Supple)	2.5Cr	2.4Cr	2.5Cr	4Cr	4.8Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	131.8Cr	191.6Cr	229Cr	314.3Cr	319.2Cr
Depreciation & Amortization - CF	36Cr	37Cr	39Cr	39Cr	38Cr
Amortization of Goodwill and Intangible Assets - (CF)	134.2Cr	143.4Cr	161.9Cr	148.5Cr	148.3Cr
Depreciation & Amortization, Total	170.7Cr	180.7Cr	201.2Cr	187.6Cr	186.5Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	30L	40L	-	55Cr	64Cr
Stock-Based Compensation (CF)	-	-	-	-	-
Other Operating Activities, Total	-45Cr	20Cr	71Cr	73Cr	5.3Cr
Change In Accounts Receivable	54Cr	-50Cr	-17Cr	-63Cr	-50Cr
Change In Inventories	-57Cr	-98Cr	-76Cr	50Cr	-36Cr
Change in Other Net Operating Assets	-27Cr	107.8Cr	-20L	-283.3Cr	58Cr
Cash from Operations	227.2Cr	351.9Cr	408Cr	332.6Cr	548.1Cr
Capital Expenditure	-41Cr	-37Cr	-28Cr	-51Cr	-55Cr
Sale of Property, Plant, and Equipment	20L	40L	30L	50L	70L
Cash Acquisitions	-	-107.6Cr	-	-1.57TCr	-
Sale (Purchase) of Intangible assets	-20Cr	-45Cr	-22Cr	-5.7Cr	-6.4Cr
Investment in Marketable and Equity Securities, Total	-	-	-	98Cr	-
Cash from Investing	-61Cr	-189.2Cr	-50Cr	-1.53TCr	-61Cr
Long-Term Debt Issued, Total	40Cr	123.4Cr	-	1.25TCr	371.6Cr
Total Debt Issued	40Cr	123.4Cr	-	1.25TCr	371.6Cr
Long-Term Debt Repaid, Total	-320.5Cr	-117.9Cr	-146.6Cr	-8.9Cr	-881.5Cr
Total Debt Repaid	-320.5Cr	-117.9Cr	-146.6Cr	-8.9Cr	-881.5Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-3.4Cr	-4.5Cr	-4.3Cr	-4.6Cr	-2Cr
Common Dividends Paid	-50Cr	-40Cr	-58Cr	-69Cr	-94Cr
Common & Preferred Stock Dividends Paid	-50Cr	-40Cr	-58Cr	-69Cr	-94Cr
Cash from Financing	-333.6Cr	-39Cr	-208.5Cr	1.16TCr	-606.2Cr
Foreign Exchange Rate Adjustments	2.9Cr	2.9Cr	-3.5Cr	-1.5Cr	-3.9Cr
Net Change in Cash	-164.5Cr	126.9Cr	146.2Cr	-35Cr	-123.1Cr
Supplemental Items
Cash Interest Paid	20Cr	64Cr	16Cr	9.1Cr	56Cr
Cash Income Tax Paid (Refund)	45Cr	-7.1Cr	47Cr	58Cr	142.2Cr
Levered Free Cash Flow	308.72Cr	50Cr	293.62Cr	455.62Cr	393.9Cr
Unlevered Free Cash Flow	318.29Cr	57Cr	297Cr	462.69Cr	426.02Cr
Change In Net Working Capital	-64Cr	215.2Cr	62Cr	-53Cr	72Cr
Net Debt Issued / Repaid	-280.5Cr	5.5Cr	-146.6Cr	1.24TCr	-509.9Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.97	4.7	5.45	5.81	6.7
Return on Total Capital	5.79	6.79	7.76	8.08	9.39
Return On Equity %	7.48	9.81	10.69	13.36	12.79
Return on Common Equity	7.48	9.81	10.69	13.36	12.79
Margin Analysis
Gross Profit Margin %	77.85	78.35	77.48	80.78	82.68
SG&A Margin	40.65	42.87	43.72	42.87	37.46
EBITDA Margin %	23.73	24.29	26.04	28.06	31.08
EBITA Margin %	22	22.73	24.52	26.69	29.9
EBIT Margin %	13.76	14.87	16.39	19.94	23.88
Income From Continuing Operations Margin %	8.09	10.5	11.5	14.28	12.96
Net Income Margin %	8.09	10.5	11.5	14.28	12.96
Net Avail. For Common Margin %	8.09	10.5	11.5	14.28	12.96
Normalized Net Income Margin	7.69	8.7	9.7	12.6	13.16
Levered Free Cash Flow Margin	18.94	2.75	14.75	20.71	15.99
Unlevered Free Cash Flow Margin	19.53	3.1	14.92	21.03	17.3
Asset Turnover
Asset Turnover	0.46	0.51	0.53	0.47	0.45
Fixed Assets Turnover	7.19	8.05	8.89	9.54	11.73
Receivables Turnover (Average Receivables)	6.5	7.06	7.02	6.88	7
Inventory Turnover (Average Inventory)	1.46	1.12	1.06	1.01	1.01
Short Term Liquidity
Current Ratio	0.98	1.39	1.66	1.52	1.44
Quick Ratio	0.59	0.87	1.08	1.01	0.9
Operating Cash Flow to Current Liabilities	0.26	0.43	0.51	0.39	0.62
Days Sales Outstanding (Average Receivables)	56.12	51.69	52	53.2	52.14
Days Outstanding Inventory (Average Inventory)	249.57	326.89	344.78	363.84	361.83
Average Days Payable Outstanding	330.77	300.06	324.83	424.39	346.69
Cash Conversion Cycle (Average Days)	-25.09	78.52	71.95	-7.35	67.28
Long Term Solvency
Total Debt/Equity	29.12	26.85	18.83	66.75	46.8
Total Debt / Total Capital	22.55	21.17	15.85	40.03	31.88
LT Debt/Equity	28.64	26.43	18.44	66.42	46.5
Long-Term Debt / Total Capital	22.19	20.83	15.52	39.83	31.68
Total Liabilities / Total Assets	47.25	44.52	41.07	56.1	52.16
EBIT / Interest Expense	14.66	26.35	60.44	38.82	11.44
EBITDA / Interest Expense	25.82	43.89	97.7	55.42	15.07
(EBITDA - Capex) / Interest Expense	23.14	40.29	92.57	50.93	13.99
Total Debt / EBITDA	1.35	1.23	0.79	2.67	1.5
Net Debt / EBITDA	0.77	0.45	-0.16	1.92	1.06
Total Debt / (EBITDA - Capex)	1.5	1.34	0.83	2.9	1.62
Net Debt / (EBITDA - Capex)	0.86	0.49	-0.17	2.09	1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.77	11.95	9.13	10.51	11.93
Gross Profit, 1 Yr. Growth %	-6.38	12.67	7.92	12.82	14.58
EBITDA, 1 Yr. Growth %	-19.37	14.61	13.48	11.99	27.08
EBITA, 1 Yr. Growth %	-20.32	15.7	13.93	12.71	28.71
EBIT, 1 Yr. Growth %	-22.33	21	14.45	22.17	38.82
Earnings From Cont. Operations, 1 Yr. Growth %	-16.64	45.37	19.52	37.25	1.56
Net Income, 1 Yr. Growth %	-16.64	45.37	19.52	37.25	1.56
Normalized Net Income, 1 Yr. Growth %	-26.31	26.73	15.3	29.89	11.12
Diluted EPS Before Extra, 1 Yr. Growth %	-16.66	45.44	19.6	37.35	1.5
Accounts Receivable, 1 Yr. Growth %	-3.68	10.17	9.45	15.75	5.04
Inventory, 1 Yr. Growth %	28.29	33.49	9.42	-10.03	12.3
Net Property, Plant and Equip., 1 Yr. Growth %	2.41	-2.57	0.45	5.34	-22.53
Total Assets, 1 Yr. Growth %	-3.82	8.08	-0.12	52.31	-9.72
Tangible Book Value, 1 Yr. Growth %	-22.45	-61.51	-178.62	-1.22T	-32.1
Common Equity, 1 Yr. Growth %	7.69	13.68	6.09	13.45	-0.43
Cash From Operations, 1 Yr. Growth %	-40.79	54.89	15.94	-18.48	64.79
Capital Expenditures, 1 Yr. Growth %	12.64	-9.51	-25.34	83.39	9.06
Levered Free Cash Flow, 1 Yr. Growth %	9.48	-83.78	400.11	45.07	-11.73
Unlevered Free Cash Flow, 1 Yr. Growth %	8.52	-82.24	355.87	45.76	-6.02
Dividend Per Share, 1 Yr. Growth %	-20	45	20.69	35.71	21.05
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.19	1.61	10.53	9.82	11.22
Gross Profit, 2 Yr. CAGR %	-1.94	2.7	10.27	11.51	13.7
EBITDA, 2 Yr. CAGR %	-14.31	-3.87	15.81	16.23	17.84
EBITA, 2 Yr. CAGR %	-15.69	-3.98	16.71	17.05	18.9
EBIT, 2 Yr. CAGR %	-21.79	-3.06	20.63	24.02	27.98
Earnings From Cont. Operations, 2 Yr. CAGR %	-24.51	10.09	31.81	28.08	18.06
Net Income, 2 Yr. CAGR %	-24.51	10.09	31.81	28.08	18.06
Normalized Net Income, 2 Yr. CAGR %	-25.01	-3.36	24.12	28.69	23.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-24.53	10.13	31.88	28.17	18.07
Accounts Receivable, 2 Yr. CAGR %	-5.75	3.01	9.81	12.56	10.27
Inventory, 2 Yr. CAGR %	12.21	36.77	20.85	-0.78	0.52
Net Property, Plant and Equip., 2 Yr. CAGR %	0.88	-0.11	-1.07	2.87	-9.66
Total Assets, 2 Yr. CAGR %	-4.67	1.96	3.9	23.34	17.96
Tangible Book Value, 2 Yr. CAGR %	-31.3	-45.36	-44.99	196.77	183.53
Common Equity, 2 Yr. CAGR %	4.36	10.65	9.82	9.71	6.28
Cash From Operations, 2 Yr. CAGR %	-6.68	-4.23	34.01	-2.78	15.9
Capital Expenditures, 2 Yr. CAGR %	7.32	0.96	-17.8	17.02	41.42
Levered Free Cash Flow, 2 Yr. CAGR %	-0.63	-57.85	-2.48	178.57	11.99
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.27	-56.1	-3.4	166.49	15.85
Dividend Per Share, 2 Yr. CAGR %	-30.16	7.7	32.29	27.98	28.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.46	2.31	4.06	10.52	10.52
Gross Profit, 3 Yr. CAGR %	-4.7	2.7	4.41	11.89	12.52
EBITDA, 3 Yr. CAGR %	-15.72	-5.59	2.64	16.88	18.76
EBITA, 3 Yr. CAGR %	-16.81	-6.31	2.77	17.88	19.78
EBIT, 3 Yr. CAGR %	-25.13	-9.54	4.16	25.06	27.29
Earnings From Cont. Operations, 3 Yr. CAGR %	-30.39	-6.08	13.14	33.6	18.55
Net Income, 3 Yr. CAGR %	-30.39	-6.08	13.14	33.6	18.55
Normalized Net Income, 3 Yr. CAGR %	-27.88	-10.67	4.32	30.31	24.63
Diluted EPS Before Extra, 3 Yr. CAGR %	-30.39	-6.06	13.2	33.68	18.58
Accounts Receivable, 3 Yr. CAGR %	-3.82	-0.72	5.11	11.75	9.99
Inventory, 3 Yr. CAGR %	16.54	22.44	26.97	9.53	3.4
Net Property, Plant and Equip., 3 Yr. CAGR %	10.63	-0.28	0.07	1.02	-6.41
Total Assets, 3 Yr. CAGR %	14.62	-0.6	1.26	18.03	11.6
Tangible Book Value, 3 Yr. CAGR %	-10.46	-43.36	-38.32	50.22	84.89
Common Equity, 3 Yr. CAGR %	8.65	7.38	9.11	11.02	6.22
Cash From Operations, 3 Yr. CAGR %	-27.58	10.49	2.07	13.55	15.92
Capital Expenditures, 3 Yr. CAGR %	10.97	1.39	-8.7	7.41	14.3
Levered Free Cash Flow, 3 Yr. CAGR %	-14.92	-45.69	1.36	13.85	88.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	-14.13	-43.69	0.42	13.28	87
Dividend Per Share, 3 Yr. CAGR %	-44.97	-10.9	11.87	33.42	25.63
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.84	1.15	1.91	5.25	6.87
Gross Profit, 5 Yr. CAGR %	1.89	1.37	1.02	6.14	8.48
EBITDA, 5 Yr. CAGR %	1.25	-3.93	-4.3	3.23	9.8
EBITA, 5 Yr. CAGR %	1.11	-4.34	-4.74	3.09	10.36
EBIT, 5 Yr. CAGR %	-0.43	-8.21	-9.39	3.65	15.29
Earnings From Cont. Operations, 5 Yr. CAGR %	1.71	-6.1	-10.13	6.32	15.09
Net Income, 5 Yr. CAGR %	1.71	-6.1	-10.13	6.32	15.09
Normalized Net Income, 5 Yr. CAGR %	-1.39	-8.84	-10.39	4.47	13.77
Diluted EPS Before Extra, 5 Yr. CAGR %	1.57	-6.17	-10.11	6.37	15.12
Accounts Receivable, 5 Yr. CAGR %	-4.54	-1.48	1.41	4.39	7.14
Inventory, 5 Yr. CAGR %	12.68	24.07	20.36	12.56	15.64
Net Property, Plant and Equip., 5 Yr. CAGR %	2.62	5.01	5.79	0.97	-3.94
Total Assets, 5 Yr. CAGR %	11.39	13.65	10.21	8.36	7.64
Tangible Book Value, 5 Yr. CAGR %	39.22	-17.91	-26.31	9.86	13.54
Common Equity, 5 Yr. CAGR %	13.52	11.27	9.12	8.31	7.97
Cash From Operations, 5 Yr. CAGR %	-6.18	-2.75	-7.36	4.98	7.39
Capital Expenditures, 5 Yr. CAGR %	11.49	8.65	-1.58	7.37	8.76
Levered Free Cash Flow, 5 Yr. CAGR %	-0.75	-25.18	-10.15	7.82	6.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.37	-23.78	-9.99	7.88	7.75
Dividend Per Share, 5 Yr. CAGR %	-3.98	-18.37	-21.84	2.99	18.13